6-Bromo-1H-indazol-3-amine(CAS: 404827-77-6)

6-Bromo-1H-indazol-3-amine (CAS: 404827-77-6) falls under various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a chemical substance requiring proper handling and disposal to mitigate environmental and health risks. Ensure compliance with local and international regulations for its transportation, storage, and use.

Several alternatives to 6-Bromo-1H-indazol-3-amine (CAS: 404827-77-6) exist in synthesis, including related indazol compounds and other heterocycles. Common substitutes include 6-iodo-1H-indazol-3-amine and 6-chloro-1H-indazol-3-amine. These alternatives provide similar functional groups for various synthetic routes.

Research on 6-Bromo-1H-indazol-3-amine (CAS: 404827-77-6) is primarily focused on its potential as a medicinal and pharmaceutical compound due to its bioactivity. Market trends indicate growing interest in its application in developing new drugs, particularly in areas such as antiviral and anticancer therapies. The compound's unique properties make it a valuable target for further investigation.

Waste containing 6-Bromo-1H-indazol-3-amine (CAS: 404827-77-6) should be collected in appropriate containers and stored in a secure, well-ventilated area. Incineration is recommended for final disposal, and professional waste disposal services should be utilized. Environmental precautions include minimizing exposure to air and water to prevent contamination. Follow local and international guidelines for hazardous waste management.